PureTech Health (PRTC) Current Assets (2019 - 2025)
PureTech Health (PRTC) reported Current Assets of $305.0 million for Q4 2025, down 21.03% year-over-year from $386.3 million in Q4 2024, and down 11.43% quarter-over-quarter from $344.4 million in Q2 2025.
PureTech Health (PRTC) Current Assets (2019 - 2025) Analysis & Trends
PureTech Health (PRTC) has 7 years of Current Assets data on file, last reported at $305.0 million in Q4 2025.
- Current Assets for Q4 2025 came in at $305.0 million, down 21.03% year-over-year; the trailing twelve-month figure through Dec 2025 was $305.0 million (down 21.03% YoY), and the FY2025 annual result was $305.0 million, down 21.03% from the prior year.
- Current Assets fell to $305.0 million in Q4 2025 per PRTC's latest filing, from $344.4 million in the prior quarter.
- Over five years, Current Assets peaked at $508.8 million in Q2 2024 and troughed at $305.0 million in Q4 2025.
- A 5-year average of $397.1 million and a median of $386.2 million in 2022 frame the typical range for Current Assets.
- The sharpest annual moves came in 2021 and 2025: Current Assets increased 21.11% in 2021, then plunged 32.32% in 2025.
- A 5-year view of Current Assets shows it stood at $501.8 million in 2021, then fell by 23.04% to $386.2 million in 2022, then slipped by 10.1% to $347.2 million in 2023, then advanced by 11.25% to $386.3 million in 2024, then dropped by 21.03% to $305.0 million in 2025.
- Business Quant data shows PRTC's Current Assets at $305.0 million in Q4 2025, $344.4 million in Q2 2025, and $386.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 305.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 305.02 Mn |
| Jun 30, 2025 | 344.39 Mn |
| Dec 31, 2024 | 386.26 Mn |
| Jun 30, 2024 | 508.81 Mn |
| Dec 31, 2023 | 347.20 Mn |
| Dec 31, 2022 | 386.19 Mn |
| Dec 31, 2021 | 501.81 Mn |
| Dec 31, 2020 | 414.35 Mn |
| Dec 31, 2019 | 168.85 Mn |